Corporate DisclosureSILCOPHL
SILCOPHL Corporate Disclosure — 23 August 2020
Announcement summary
- What happened
- SILCOPHL published a corporate disclosure on 23 August 2020. Read the full announcement for details.
- Company
- Silco Pharmaceuticals Limited
- Announcement published
Original announcement
The Company has informed that the Company has signed its first export agreement with ZAID ELYAS ADIL LTD, Afghanistan. The Company will export total of 13 different medicines to Afghanistan for next 5 years commencing from August 2020. Total export value (estimated) will be 3,80,000.00 US Dollar. First export value (as per PI) will be 26,780.00 US Dollar against 13 different medicines to Afghanistan and estimated profit will be 30% against the export.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace8c5a6b0000400565e5
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SILCOPHL
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.